jiayi-li23/proxann_data huggingface dataset:
Bill 111-HR-1050 — Health / R&D
Subject: Health

Human Cloning Prohibition Act of 2009 - Amends the federal criminal code to prohibit any public or private person or entity, in or affecting interstate commerce, from: (1) performing or attempting to perform human cloning; (2) participating in an attempt to perform human cloning; or (3) shipping, receiving, or importing the product of human cloning for any purpose. Sets forth criminal and civil penalties for violations.Provides that nothing in this Act shall restrict areas of scientific research not specifically prohibited by this Act, including research in the use of nuclear transfer or other cloning techniques to produce molecules, DNA, cells other than human embryos, tissues, organs, plants, or animals other than humans.
Bill 111-HR-1210 — Health / R&D
Subject: Health

Arthritis Prevention, Control, and Cure Act of 2010 - (Sec. 2) Amends the Public Health Service Act to authorize the Secretary of Health and Human Services to develop and implement a National Arthritis Action Plan. Authorizes the Secretary, directly or through competitive grants, to conduct, support, and promote the coordination of research, investigations, demonstrations, training, and studies relating to the control, prevention, and surveillance of arthritis and other rheumatic diseases. Permits the Secretary, upon request of a grantee, to provide training, technical assistance, supplies, equipment, or services or detail any officer or employee of the Department of Health and Human Services (HHS) to aid the grantee in carrying out grant activities. Requires the Secretary to reduce the amount of payments under the grant by an amount equal to the costs of detailing personnel and the fair market value of any supplies, equipment, or services provided by the Secretary. Authorizes the Secretary to provide additional grant support to encourage the expansion of research related to the prevention and management of arthritis at the Centers for Disease Control and Prevention (CDC). Authorizes the Secretary to coordinate and carry out national education and outreach activities for arthritis and other rheumatic diseases, which may include public awareness campaigns, public service announcements, and community partnership workshops. Authorizes the Secretary to: (1) emphasize prevention, early diagnosis, and appropriate management of arthritis and opportunities for effective patient self-management; and (2) give priority to reaching high-risk or underserved populations. Authorizes the Secretary to award grants to a state or Indian tribe to provide support for comprehensive arthritis control and prevention programs and to enable such state or Indian tribe to provide public health surveillance, prevention, and control activities related to arthritis and other rheumatic diseases. Authorizes appropriations for FY2012-FY2016. (Sec. 3) Authorizes the Secretary to expand and intensify programs of the National Institutes of Health (NIH) with respect to research and related activities designed to improve the outcomes and quality of life for children with arthritis and other rheumatic diseases. (Sec. 4) Authorizes the Secretary to award institutional training grants to institutions to support pediatric rheumatology training to ensure an adequate future supply of pediatric rheumatologists.
Bill 111-HR-1230 — Health / R&D
Subject: Health

Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010 - (Sec. 2) Amends the Public Health Service Act to authorize the Secretary of Health and Human Services (HHS) to conduct research on acquired bone marrow failure diseases, which may address factors including: (1) trends in the characteristics of individuals who are diagnosed with such diseases, including age, race and ethnicity, general geographic location, sex, and family history; (2) the genetic and environmental factors, including exposure to toxins, that may be associated with developing such diseases; (3) approaches to treating such diseases; and (4) outcomes for individuals treated for such diseases, including outcomes for recipients of stem cell therapeutic products. Authorizes the Secretary to collaborate with the Radiation Injury Treatment Network of the C.W. Bill Young Cell Transplantation Program to: (1) augment data for studies; (2) access technical assistance that may be provided by the Network; or (3) perform joint research projects. (Sec. 3) Authorizes the Secretary to establish and coordinate outreach and informational programs targeted to minority populations, including Hispanic, Asian-American, Native Hawaiian, and Pacific Islander populations, that are affected by acquired bone marrow failure diseases. Includes among program activities: (1) making information about treatment options and clinical trials for such diseases publicly available; and (2) providing referral services for treatment options and clinical trials. (Sec. 4) Authorizes the Secretary, acting through the Director of the Agency for Healthcare Research and Quality, to award grants to researchers to study best practices with respect to diagnosing acquired bone marrow failure diseases and providing care to individuals with such diseases.
Bill 111-HR-1350 — Health / R&D
Subject: Health

Post-Abortion Depression Research and Care Act of 2009 - Requires the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH) and the Director of the National Institute of Mental Health (NIMH), to expand and intensify NIMH research and related activities with respect to post-abortion depression and psychosis. Requires the Director of NIMH to: (1) conduct or support research to expand the understanding of the causes of, and to find a cure for, such post-abortion conditions; and (2) conduct a study to determine the incidence and prevalence of cases of post-abortion conditions and the symptoms, severity, and duration of such cases, toward the goal of more fully identifying the characteristics of such cases and developing diagnostic techniques. Requires the Secretary to make grants to establish, operate, and coordinate effective and cost-efficient systems for the delivery of essential services to individuals with such post-abortion conditions.
Bill 111-HR-1483 — Health / R&D
Subject: Health

National Neurotechnology Initiative Act - Defines "neurotechnology" to mean the science and technology that allows an individual to analyze, understand, treat, and heal the brain and nervous system.Requires the Secretary of Health and Human Services to implement a National Neurotechnology Initiative, under which the Secretary shall: (1) establish goals, priorities, and metrics for evaluation for federal neurotechnology research, development, and commercialization; (2) increase the investment in federal research, development, and translational programs in neurotechnology to achieve such goals; and (3) increase interagency coordination.Requires the Secretary to establish the National Neurotechnology Coordination Office and the National Neurotechnology Advisory Council.Requires the Director of the National Institutes of Health (NIH) to develop the Blueprint for Neuroscience Research to: (1) identify pervasive challenges in neuroscience and any technological barriers to solving such challenges; and (2) support the development of new tools, training opportunities, and other resources to assist neuroscientists in basic and clinical research. Directs the Commissioner of Food and Drugs to require the Directors of the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, and the Center for Devices and Radiological Health to improve the timelines of the review process for neurology and psychiatry.Requires the Director of the National Neurotechnology Coordination Office to establish the American Neurotechnology Study Center.
Bill 111-HR-1654 — Health / R&D
Subject: Taxation

Cures Can Be Found Act of 2009 - Amends the Internal Revenue Code to allow tax credits for: (1) donations to stem cell research or storage facilities; and (2) donations of umbilical cord blood. Allows credits only for donations to facilities that do not engage in research on stem cells derived from human embryos. Allows a business tax credit for stem cell research and storage expenses.
Bill 111-HR-1715 — Health / R&D
Subject: Health

Protection for Participants in Research Act of 2009 - Amends the Public Health Service Act to require all human subject research conducted, supported, or otherwise subject to federal regulation, to be conducted in accordance with the Common Rule and the vulnerable-population rules, as set forth in the Code of Federal Regulations. Requires the Secretary of Health and Human Services to review and harmonize such regulations. Requires informed consent before an individual may be a subject of human research. Requires an Institutional Review Board to approve all human subject research proposals. Directs the Secretary to establish criteria for determining whether a human subject research project must be conducted in accordance with a data safety and monitoring plan. Prohibits grants or awards to a public entity or private academic institution that does not have a program to educate investigators and Board members on the protection of human research subjects. Prohibits the use of federal funds for classified human subject research if: (1) the Board has waived the informed consent requirement; or (2) the research is exempt from Board review. Establishes the Office of Human Research Protections within the Office of the Secretary. Requires the Director of the Office to: (1) provide for the protection of human research subjects; (2) establish criteria regarding assurance of compliance with Common Rule requirements; and (3) coordinate federal activities with respect to the protection of human research subjects. Authorizes the Director to make grants for a model education program. Requires the Secretary to: (1) promulgate regulations enhancing the protection of people with diminished decision-making capacity participating in human subject research; and (2) study whether the number of certain members of Institutional Review Boards should be increased.
Bill 111-HR-1816 — Health / R&D
Subject: Health

Ovarian Cancer Biomarker Research Act of 2009 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate Ovarian Cancer Biomarker Centers of Excellence to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer, focusing on translational research of such biomarkers. Permits federal funds to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation of such biomarkers; (3) the development and implementation of clinical and epidemiological research on the utilization of such biomarkers; (4) the development and implementation of repositories for new tissue, urine, serum, and other biological specimens; and (5) genetics, proteomics, and pathways of ovarian cancer as they relate to the discovery and development of biomarkers. Requires the Director to: (1) make available for research banked serum and tissue specimens from clinical research regarding ovarian cancer that was funded by the Department of Health and Human Services (HHS); and (2) establish an Ovarian Cancer Biomarker Clinical Trial Committee to assist in designing and implementing national clinical trials to determine the utility of using such biomarkers. Requires a national data center to be established in, and supported by, the Institute to conduct statistical analyses of trial data and to store such analyses and data, which shall be used to establish clinical guidelines to provide the medical community with information regarding the use of validated biomarkers.
Bill 111-HR-2109 — Health / R&D
Subject: Health

Childhood Cancer Survivorship Research and Quality of Life Act of 2009 - Amends the Public Health Service Act to direct the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand and intensify the CDC's cancer control programs, including programs for conducting surveillance activities or supporting state comprehensive cancer control programs. Requires the Director of the National Cancer Institute to coordinate the activities of the National Institutes of Health (NIH) with respect to cancer survivorship, including child cancer survivorship. Requires the Director of NIH, acting through the Director of the Institute, to make grants for research relating to: (1) childhood cancer survivors within minority populations; and (2) health disparities in cancer survivorship outcomes within minority or other medically underserved populations. Requires the Director of NIH to conduct or support research to evaluate systems of follow-up care for childhood cancer survivors. Directs the Secretary to make grants to establish or improve training programs for health care professionals to: (1) improve the quality of immediate and long-term follow-up care for survivors of childhood cancers and their families; and (2) ensure that such care is linguistically and culturally competent. Requires the Director of NIH to make grants to establish pilot programs to develop, study, or evaluate model systems for monitoring and caring for childhood cancer survivors. Requires the Secretary to make grants to: (1) establish and operate a clinic for comprehensive long-term follow-up services for childhood cancer survivors; and (2) improve physical and psychosocial care for childhood cancer survivors.
Bill 111-HR-2275 — Health / R&D
Subject: Health

Inflammatory Bowel Disease Research and Awareness Act - Amends the Public Health Service Act to require the Centers for Disease Control and Prevention (CDC) to: (1) conduct, support, and expand epidemiology research on inflammatory bowel disease (IBD) (i.e., Crohn's disease and ulcerative colitis) in pediatric and adult populations and establish a registry of pediatric IBD patients; (2) enter into cooperative agreements to develop and administer such epidemiology research and the pediatric IBD registry; and (3) award grants to increase awareness of IBD among the general public and health care providers. Requires the Director of the National Institutes of Health (NIH) to include information on IBD research in the biennial reports of NIH to Congress. Expresses the sense of Congress that the Directors of NIH and the National Institute of Diabetes and Digestive and Kidney Diseases should support specified research and training goals for inflammatory bowel disease.
Bill 111-HR-2408 — Health / R&D
Subject: Health

Scleroderma Research and Awareness Act of 2010 - Amends the Public Health Service Act to authorize the Director of the National Institutes of Health (NIH) to expand, intensify, and coordinate NIH activities with respect to scleroderma, with particular emphasis on: (1) research focused on the etiology of scleroderma and the development of new treatment options; (2) clinical research to evaluate new treatments options; and (3) basic research on the relationship between scleroderma and secondary conditions, such as pulmonary hypertension, gastroparesis, Raynaud's phenomenon, Sjogren's Syndrome. Authorizes the Secretary of Health and Human Services (HHS) to carry out an educational campaign to increase public awareness of scleroderma. Permits print, video, and web-based materials distributed through this campaign to include: (1) basic information on scleroderma and its symptoms; and (2) information on the incidence and prevalence of scleroderma, diseases and conditions affiliated with scleroderma, or the importance of early diagnosis and treatment of scleroderma.
Bill 111-HR-2463 — Health / R&D
Subject: Taxation

Taxpayers' Cancer Research Funding Act of 2009- Amends the Internal Revenue Code to allow taxpayers to designate on their tax returns a $5 contribution to the Breast and Prostate Cancer Research Fund ($10 for joint returns). Establishes in the Treasury the Breast and Prostate Cancer Research Fund to award grants for breast or prostate cancer research.
Bill 111-HR-2502 — Health / R&D
Subject: Health

Comparative Effectiveness Research Act of 2009 - Amends title XI (General Provisions, Peer Review, and Administrative Simplification) of the Social Security Act to provide for a program of comparative effectiveness research for health care. Defines "comparative effectiveness research" as research evaluating and comparing the implications and outcomes of two or more health care strategies to address a particular medical condition. Establishes the Health Care Comparative Effectiveness Research Institute as a nonprofit, nongovernmental corporation to conduct research on the effectiveness of health care treatments, including pharmaceuticals, medical devices and procedures, and other therapies. Requires the Institute to: (1) identify national priorities for comparative clinical effectiveness research; (2) establish and update a research project agenda and provide for peer review of research; (3) establish a standing methodology committee for developing the science of comparative effectiveness research; and (4) disseminate research findings. Amends the Internal Revenue Code to establish in the Treasury the Comparative Effectiveness Research Trust Fund. Provides revenues for the Trust Fund by: (1) transferring amounts from certain appropriations for comparative effectiveness research, from the General Fund, and from the Medicare Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds; and (2) imposing a fee on certain accident or health insurance policies and self-insured health plans. Requires the Comptroller General to review financial audits of the Institute and assess the adequacy and use of funding. Terminates all funding for the Trust Fund after FY2020.
Bill 111-HR-2949 — Health / R&D
Subject: Health

Prostate Cancer Research and Prevention Act - Amends the Public Health Service Act to authorize appropriations through FY2015 for: (1) the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to make grants to states and local health departments to carry out preventive health measures related to prostate cancer; and (2) the Director of the National Cancer Institute to expand, intensify, and coordinate prostate cancer research activities.
Bill 111-HR-3002 — Health / R&D
Subject: Health

Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2009 or the PATIENTS Act of 2009 - Prohibits the Secretary of Health and Human Services (HHS) from using data obtained from the conduct of comparative effectiveness research, including such research that is conducted or supported using funds appropriated under the American Recovery and Reinvestment Act of 2009, to deny coverage of an item or service under a federal health care program. Requires the Secretary to ensure that comparative effectiveness research conducted or supported by the federal government accounts for factors contributing to differences in the treatment response and preferences of patients, including patient-reported outcomes, genomics and personalized medicine, the unique needs of health disparity populations, and indirect patient benefits.
Bill 111-HR-3475 — Health / R&D
Subject: Health

Accelerate Cures for Patients Act of 2009 - Amends the Public Health Service Act to authorize additional appropriations to the National Institutes of Health (NIH) to conduct or support medical research that relates to cancer, cardiovascular disease, diabetes, Alzheimer's disease, Parkinson's disease, or other diseases or conditions and that has the greatest potential for near-term clinical benefit in human patients, as indicated by substantial evidence from basic research or by substantial clinical evidence. Allows such evidence to include: (1) evidence of improvement in one or more human patients suffering from illness or injury, as documented in reports by professional medical or scientific associations or in peer-reviewed medical or scientific literature; and (2) approval for use in human trials by the Food and Drug Administration (FDA).
Bill 111-HR-3675 — Health / R&D
Subject: Health

National Quality Cancer Care Demonstration Project Act of 2009 - Directs the Secretary of Health and Human Services to establish a quality cancer care demonstration project for the purpose of establishing quality metrics and aligning payment incentives under title XVIII (Medicare) of the Social Security Act in the areas of treating planning and follow-up cancer care for Medicare beneficiaries with cancer.
Bill 111-HR-4160 — Health / R&D
Subject: Health

Environmental Hormone Disruption Research Act of 2009 - Amends the Public Health Service Act to require the Director of the National Institute of Environmental Health Sciences to establish a comprehensive program to: (1) research the health effects on women and children that may result through disruption of the hormone systems; (2) carry out research, development, and demonstrations on technologies to mitigate the occurrence of hormone-disrupting pollutants in the environment and their unintended effects on ecological and wildlife health, in cooperation with the United States Geological Survey (USGS); and (3) coordinate U.S. research on hormone disruption with research conducted in other nations. Requires the program to provide for: (1) the collection and dissemination of scientifically valid information on human health effects of hormone-disrupting pollutants, the extent of human exposure to such pollutants, and the exposure of wildlife species to such pollutants and possible associated health effects; and (2) research on mechanisms by which such pollutants interact with biological systems, testing for hormone disruption, and the identity and fate of hormone-disrupting pollutants in the environment. Directs the House Committee on Energy and Commerce to hold a hearing on program implementation. Gives the Director principal responsibility for conducting and coordinating research on the unintended effects of hormone-disrupting pollutants on human health and the environment. Requires the Secretary of Health and Human Services (HHS) to establish the Hormone Disruption Research Interagency Commission. Establishes a Hormone Disruption Research Panel to make recommendations on the design and implementation of the program.
Bill 111-HR-4161 — Health / R&D
Subject: Health

Women's Environmental Health and Disease Prevention Act of 2009 - Amends the Public Health Service Act to require the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of centers to conduct multidisciplinary research on environmental factors that may be related to the development of women's health conditions. Requires each such center to: (1) conduct basic or clinical research; (2) develop protocols and conduct training programs for physicians, scientists, nurses, and other health and allied health professionals; (3) disseminate information to such professionals and the public; and (4) emphasize activities that are directed toward preventing the development in women of the diseases and conditions involved. Allows a center to use funds to provide stipends for health and allied health professionals enrolled in training programs. Requires each center to establish and maintain ongoing collaborations with community organizations in the geographic area served by the center, including organizations that represent women or children with disorders that appear to stem from environmental factors. Requires the Director to provide for the coordination of information among centers and ensure regular communication between them. Directs the House Committee on Energy and Commerce to hold a hearing on the Director's implementation of this Act.